Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
New Add-On treatment tested for Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing whether adding a supplement called Seleno-L Methionine (SLM) to two standard kidney cancer drugs (axitinib and pembrolizumab) is safe and more effective. It will involve about 55 adults with advanced kidney cancer that has spread or cannot be removed by surg…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Apr 04, 2026 04:49 UTC
-
Scientists test common bone drug in fight against rare bone cancer
Disease control OngoingThis early-stage study is testing whether a drug called zoledronic acid, which is normally used to strengthen bones, can help control tumor growth in patients with a type of bone cancer called chondrosarcoma. Participants receive the drug before their standard surgery and again a…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC